Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Atlas Arteria ( (AU:ALX) ) has provided an update.
Atlas Arteria has announced the lapse of 239,560 performance rights (ASX code ALXAL) effective 31 December 2025, after the conditional rights to securities failed to meet required vesting conditions or became incapable of being satisfied. The cessation of these performance rights slightly reduces the company’s potential future issued capital and reflects the operation of its performance-based incentive structures, with limited immediate impact expected on ordinary shareholders but some implications for participants in equity incentive plans.
The most recent analyst rating on (AU:ALX) stock is a Hold with a A$5.09 price target. To see the full list of analyst forecasts on Atlas Arteria stock, see the AU:ALX Stock Forecast page.
More about Atlas Arteria
Atlas Arteria is a listed global infrastructure company focused on investing in and managing toll roads and related transport assets. Through its portfolio entities, it provides long-term exposure to traffic-driven revenue streams in key markets, offering investors access to regulated and concession-based infrastructure income.
Average Trading Volume: 1,734,016
Technical Sentiment Signal: Hold
Current Market Cap: A$7.01B
For an in-depth examination of ALX stock, go to TipRanks’ Overview page.